Pfizer’s COVID Vaccine Gets Full Approval From The FDA

Vaccine Shot
Vaccine Shot (Photo/Pixabay Free Use)

The FDA has officially granted full approval to Pfizer’s COVID-19 vaccine.  

This is the first COVID-19 vaccine to be subject to a full review, and to get an approval. 

The vaccine will now be marketed as ‘Comirnaty’, and is approved for all people 16 and older.  It will remain under emergency authorization for children ages 12-15.  

Will this mean more people will get the shot? A recent poll found that 30 percent of unvaccinated people say they would be more willing to take the vaccine if it had full FDA approval.

An official statement was released by FDA Commissioner Janet Woodcock.

“The FDA’s approval of this vaccine is a milestone as we continue to battle the COVID-19 pandemic. While this and other vaccines have met the FDA’s rigorous, scientific standards for emergency use authorization, as the first FDA-approved COVID-19 vaccine, the public can be very confident that this vaccine meets the high standards for safety, effectiveness, and manufacturing quality the FDA requires of an approved product. While millions of people have already safely received COVID-19 vaccines, we recognize that for some, the FDA approval of a vaccine may now instill additional confidence to get vaccinated. Today’s milestone puts us one step closer to altering the course of this pandemic in the U.S.” 

Will this make your feel more comfortable getting the vaccine?